*Immuntherapie: ''"Now, sophisticated high-throughput technologies enable the identification of these mutated genes in cancers, leading to potent targeted immunotherapy - by so called tumor-associated–antigen-multiplex-THX-Vaccination-Strategy. Particularly THX-Vaccination-Strategies against the tumor antigens or mutated antigens have shown amazing results, showing a stronger anti-tumor immune response than several dendritic cell vaccinations. In comparison to the often used single-THX-Vaccination-Strategy - "one THX against one tumor antigen" - that is limited by the so called MHC-class-match and by the fact that one THX might not be efficient to induce an immune response or can be bypassed quickly, we have established a Multiplex-THX-Vaccination-Strategy that includes all therapeutic relevant immunogenic THX’s against one tumor antigen - "Multiplex Immunogenic THX’s (50-200 THX’s) against one tumor antigen. Furthermore, we are using the Multiplex THX’s in combination with the most upfront immuno-adjuvants. Our adjuvants have been optimized in order to improve efficacy and stability of the Multiplex THX Vaccine formulations and to reduce side effects..."'' (9500 + 3800 Euro) | *Immuntherapie: ''"Now, sophisticated high-throughput technologies enable the identification of these mutated genes in cancers, leading to potent targeted immunotherapy - by so called tumor-associated–antigen-multiplex-THX-Vaccination-Strategy. Particularly THX-Vaccination-Strategies against the tumor antigens or mutated antigens have shown amazing results, showing a stronger anti-tumor immune response than several dendritic cell vaccinations. In comparison to the often used single-THX-Vaccination-Strategy - "one THX against one tumor antigen" - that is limited by the so called MHC-class-match and by the fact that one THX might not be efficient to induce an immune response or can be bypassed quickly, we have established a Multiplex-THX-Vaccination-Strategy that includes all therapeutic relevant immunogenic THX’s against one tumor antigen - "Multiplex Immunogenic THX’s (50-200 THX’s) against one tumor antigen. Furthermore, we are using the Multiplex THX’s in combination with the most upfront immuno-adjuvants. Our adjuvants have been optimized in order to improve efficacy and stability of the Multiplex THX Vaccine formulations and to reduce side effects..."'' (9500 + 3800 Euro) |